Surgery Partners, Inc. Financials

Market Capitalization $2.62 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	2956.00
Forward PE	16.36
Price to Sales TTM	$0.88
Price to Book MRQ	$1.37
Enterprise to Revenue	2.53
Enterprise to EBITDA	12.65

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-2.03%
Operating Margin	13.02%
Return on Assets TTM	3.90%
Return on Equity TTM	3.08%

Income Statement

Revenue TTM	$2,985,299,968
Revenue per Share TTM	$23.69
Quarterly Revenue Growth	14.30%
Gross Profit TTM	$705,600,000
EBITDA	$614,100,000
Net Income to Common TTM	$-60,600,000
Diluted EPS TTM	$-0.47
Quarterly Earnings Growth YoY	14.29%

Balance Sheet

Total Cash MRQ	$243,500,000
Total Cash per Share MRQ	$1.93
Total Debt MRQ	$
Total Debt to Equity MRQ	99.38
Current Ratio MRQ	1.80
Book Value per Share MRQ	$15.00

Cash Flow

Operating Cash Flow TTM	$251,300,000
Levered Free Cash Flow TTM	$135,800,000

SGRY Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	127,114,000
Float Shares	74,847,605
Avg 10 Volume	975,580
Avg 30 Volume	None
Shares Short	11,005,039
Short Ratio	9.52
Short % of Shares	19.06%
% Held by Insiders	1.13%
% Held by Institutions	110.10%

Stock Price Summary

Beta	2.77
Fifty Two Week Low	$19.50
Fifty Two Week High	$35.30
Fifty Two Week Change	-58.76%
Day 50 MA	$22.15
Day 200 MA	$26.68

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date